Nasus Pharma Ltd. Form 6-K Summary (Nov 2025)
Nasus Pharma Ltd. filed a Form 6-K primarily to disclose the release of an updated corporate presentation on November 3, 2025 (Exhibit 99.1).
- Key Event: Release of new investor presentation materials.
- Investor Focus: Investors should review Exhibit 99.1 for current strategic details, business updates, and potentially financial metrics or pipeline status.
- Disclaimer: The filing explicitly notes the presentation is not an offering document or solicitation.
- Filing Status: Confirms status as a Foreign P